CareDx (CDNA)
(Delayed Data from NSDQ)
$23.98 USD
-0.50 (-2.04%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $24.01 +0.03 (0.13%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Income Statements
Fiscal Year end for CareDx, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 280 | 322 | 296 | 192 | 127 |
Cost Of Goods | 102 | 112 | 97 | 63 | 45 |
Gross Profit | 178 | 210 | 199 | 129 | 82 |
Selling & Adminstrative & Depr. & Amort Expenses | 382 | 287 | 229 | 152 | 106 |
Income After Depreciation & Amortization | -203 | -77 | -30 | -23 | -25 |
Non-Operating Income | 13 | 1 | -2 | 3 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | -1 |
Pretax Income | -190 | -76 | -32 | -20 | -24 |
Income Taxes | 0 | 0 | -1 | -1 | -2 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -190 | -77 | -31 | -19 | -22 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -190 | -77 | -31 | -19 | -22 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -188 | -61 | -17 | -13 | -19 |
Depreciation & Amortization (Cash Flow) | 15 | 16 | 13 | 10 | 6 |
Income After Depreciation & Amortization | -203 | -77 | -30 | -23 | -25 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 53.77 | 53.32 | 52.24 | 46.48 | 42.15 |
Diluted EPS Before Non-Recurring Items | -3.54 | -1.44 | -0.59 | -0.40 | -0.52 |
Diluted Net EPS (GAAP) | -3.54 | -1.44 | -0.59 | -0.40 | -0.52 |
Fiscal Year end for CareDx, Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 92.27 | 72.05 | 65.57 | 67.19 |
Cost Of Goods | NA | 27.95 | 25.93 | 25.61 | 24.53 |
Gross Profit | NA | 64.33 | 46.12 | 39.96 | 42.66 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 68.43 | 65.45 | 66.29 | 71.44 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -4.10 | -19.33 | -26.33 | -28.78 |
Non-Operating Income | NA | 2.73 | 2.60 | 4.70 | 5.22 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -1.37 | -16.74 | -117.93 | -23.57 |
Income Taxes | NA | 0.02 | -0.08 | 0.17 | -0.08 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -1.39 | -16.66 | -118.10 | -23.49 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.39 | -16.66 | -118.10 | -23.49 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 52.20 | 51.69 | 53.39 | 54.18 |
Diluted EPS Before Non-Recurring Items | NA | -0.03 | -0.28 | -2.21 | -0.43 |
Diluted Net EPS (GAAP) | NA | -0.03 | -0.32 | -2.21 | -0.43 |